The insulin secretory responses to glucose, arginine and glucagon-like peptide (GLP)-1-(7- 37 have been evaluated from the isolated perfused pancreas of rats with either acquired or genetic obesity, ie, a) fed ad libitum 14-mo old Sprague-Dawley rats as compared to age-matched animals subjected to two types of dietary restriction (every-other-day feeding, EOD, and 40% restriction? 40% DR), and b) 2.5-mo old genetically obese fa/fa rats as compared to the lean counterpart, In mature fed ad libitum rats, the glucose-stimulated insulin release from the perfused pancreas was increased 5-fold by addition of 0.1 nM GLP-1 (7-37), a subsequent challenge with high glucose resulted in an improvement of the first phase of insulin release, In 40% DR rats, a similar pattern of secretion was observed, with the difference of a lower response to arginine than in fed ad libitum animals, In EOD rats, the overall secretory performance of the perfused pancreas was approximately 50% lower than in the fed ad libitum group but probably adequate to the reduced weight of the animals, In genetically obese young rats, both the response to GLP-1 (7-37) anti the total insulin secretion were higher than in the lean controls. Interestingly, the maximal insulin outputs from the perfused pancreases were observed in both the groups of overweight animals, In conclusion no impairment in the secretory responsiveness of beta-cells occurs in obese animals, Conversely, at least within the age limits of the present study, the endocrine pancreas develops a compensatory ability to match the augmented insulin demand due to the over-weight. In the light of the observed great sensitivity of the isolated perfused pancreas to GLP-1 (7-37), changes in the responsiveness of beta-cells to incretins might be involved in the modulation of the endocrine pancreatic function of obese rats.
|Autori:||Masiello P; Gjinovci A; Bombara M; Wollheim CB; Bergamini E|
|Titolo:||Effects of age, diet and obesity on insulin secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)|
|Anno del prodotto:||1995|
|Appare nelle tipologie:||1.1 Articolo in rivista|